242 related articles for article (PubMed ID: 8597317)
21. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
[TBL] [Abstract][Full Text] [Related]
22. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).
Blankenhorn DH; Azen SP; Kramsch DM; Mack WJ; Cashin-Hemphill L; Hodis HN; DeBoer LW; Mahrer PR; Masteller MJ; Vailas LI; Alaupovic P; Hirsch LJ;
Ann Intern Med; 1993 Nov; 119(10):969-76. PubMed ID: 8214993
[TBL] [Abstract][Full Text] [Related]
23. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).
Hedblad B; Wikstrand J; Janzon L; Wedel H; Berglund G
Circulation; 2001 Apr; 103(13):1721-6. PubMed ID: 11282901
[TBL] [Abstract][Full Text] [Related]
24. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.
Espeland MA; Applegate W; Furberg CD; Lefkowitz D; Rice L; Hunninghake D
Am J Epidemiol; 1995 Nov; 142(10):1011-9. PubMed ID: 7485045
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
[TBL] [Abstract][Full Text] [Related]
26. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H
Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532
[TBL] [Abstract][Full Text] [Related]
27. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
de Sauvage Nolting PR; de Groot E; Zwinderman AH; Buirma RJ; Trip MD; Kastelein JJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1837-41. PubMed ID: 12912721
[TBL] [Abstract][Full Text] [Related]
28. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R
J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735
[TBL] [Abstract][Full Text] [Related]
29. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.
Blankenhorn DH; Hodis HN
Arterioscler Thromb; 1994 Feb; 14(2):177-92. PubMed ID: 8305407
[TBL] [Abstract][Full Text] [Related]
30. Carotid atherosclerosis in men with low levels of HDL cholesterol.
Wilt TJ; Rubins HB; Robins SJ; Riley WA; Collins D; Elam M; Rutan G; Anderson JW
Stroke; 1997 Oct; 28(10):1919-25. PubMed ID: 9341696
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.
Held C; Hjemdahl P; Eriksson SV; Björkander I; Forslund L; Rehnqvist N
Eur Heart J; 2001 Jan; 22(1):62-72. PubMed ID: 11133211
[TBL] [Abstract][Full Text] [Related]
32. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
[TBL] [Abstract][Full Text] [Related]
33. Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?
Stein EA
J Am Coll Cardiol; 2008 Dec; 52(25):2206-9. PubMed ID: 19095140
[No Abstract] [Full Text] [Related]
34. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
Kastelein JJ; Sager PT; de Groot E; Veltri E
Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
[TBL] [Abstract][Full Text] [Related]
36. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
37. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.
Waters D; Lespérance J; Gladstone P; Boccuzzi SJ; Cook T; Hudgin R; Krip G; Higginson L
Circulation; 1996 Aug; 94(4):614-21. PubMed ID: 8772679
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.
Vukusich A; Kunstmann S; Varela C; Gainza D; Bravo S; Sepulveda D; Cavada G; Michea L; Marusic ET
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1380-7. PubMed ID: 20522535
[TBL] [Abstract][Full Text] [Related]
39. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Kroon AA; van Asten WN; Stalenhoef AF
Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
[TBL] [Abstract][Full Text] [Related]
40. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
